Cardiomyocyte Regeneration from Circulating Bone Marrow Cells in Mice
- 1 September 2003
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 54 (3) , 319-325
- https://doi.org/10.1203/01.pdr.0000078275.14079.77
Abstract
We investigated the role of circulating bone marrow cells (BMC) in cardiomyocyte regeneration. BMC, isolated from transgenic mice expressing enhanced green fluorescent protein (GFP), were transplanted into lethally irradiated C57BL6 mice. Five weeks after bone marrow transplantation (BMT), flow cytometric analysis for GFP-positive cells confirmed reconstitution of transplanted bone marrow. Bone marrow transplant mice subsequently underwent left coronary artery ligation (myocardial infarction) or sham-operation, and were killed at 1 mo or 3 mo after operation. Infarct size was similar in bone marrow transplant mice at 1 mo (47.1 ± 5.9%) and at 3 mo (45.3 ± 7.8%), and echocardiography at 2 and 8 wk revealed decreasing left ventricular function. In infarcted heart, GFP-positive cells that expressed desmin and troponin T-C were identified by confocal microscopy. GFP and troponin T-C double-positive cells were predominantly in the peri-infarcted region (1 mo, 365 ± 45 cells/50 sections; 3 mo: 458 ± 100 cells/50 sections; p < 0.05 versus noninfarct, infarct, and sham-operated regions). Furthermore, BMC mobilization and differentiation into cardiomyocytes was found to be complete within 1 mo after myocardial infarction. These results demonstrate that circulating BMC undergo mobilization and differentiation in cardiac cells after myocardial infarction. Future studies are required to determine the molecular signaling mechanisms responsible for this phenomenon.Keywords
This publication has 34 references indexed in Scilit:
- Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and CytokinesCirculation, 2001
- Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial InfarctionCirculation, 2001
- Cell Transplantation as Future Therapy for Cardiovascular Disease?Circulation, 2000
- Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological NeovascularizationCirculation Research, 1999
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cellsThe EMBO Journal, 1999
- Survival, Integration, and Differentiation of Cardiomyocyte GraftsCirculation, 1999
- Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularizationNature Medicine, 1999
- Skeletal myoblast transplantation for repair of myocardial necrosis.Journal of Clinical Investigation, 1996
- Ischaemic myocardial injury and ventricular remodellingCardiovascular Research, 1993
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990